Facilitation of benzodiazepine discontinuation by melatonin: a new clinical approach
On the other hand, Wegovy (brand name for semaglutide), approved by FDA recently for chronic weight management along with dietary changes and physical activity, has shown substantial efficacy in reducing body weight as it influences eating patterns centrally leading to decreased calorie intake
This pairing can lower HbA1c and reduce your risk of type 2 diabetes complications
Brand-name semaglutide, sold as Wegovy or Ozempic, is FDA-approved as a finished product
Clinically backed for fat loss, lean muscle retention, and deep sleep
However, rapid escalation should only be done under medical supervision to avoid side effects like nausea and dizziness